02/09/2025
Heartening news of tentative first steps towards psychedelic access in Germany ✨💛
The Central Institute of Mental Health in Mannheim has received approval to administer psilocybin for treatment-resistant depression.
It is the first time in the European Union that psilocybin will be made available through a compassionate use scheme, in which patients with serious or life-threatening illnesses can get access to drugs that have not yet been approved.
“Experience from Switzerland shows that demand far exceeds the available supply. This is also likely to be the case in Germany,” explains programme director Professor Gerhard Gründer. “A Compassionate Use Program cannot replace approval. We must therefore continue to work on bringing psychedelics such as psilocybin into standard care for the treatment of mental illness.”
Further details in link bio đź”—